Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia

Anti-leucine-rich glioma inactivated-1 (anti-LGI1) encephalitis is a subgroup of autoimmune encephalitis. We herein report the case of a 60-year-old man who presented with typical symptoms, including short-term memory loss, mental abnormalities, hyponatremia and seizures characterized by faciobrachi...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 59; no. 2; pp. 271 - 275
Main Authors Yuan, Xiaoling, Man, Xiaoyan, Zhang, Jinbiao, Sun, Jijun, Liang, Jianhua, Ma, Hongling, Tao, Shuxin, Guo, Dong, Liu, Lifeng
Format Journal Article
LanguageEnglish
Published Japan The Japanese Society of Internal Medicine 15.01.2020
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anti-leucine-rich glioma inactivated-1 (anti-LGI1) encephalitis is a subgroup of autoimmune encephalitis. We herein report the case of a 60-year-old man who presented with typical symptoms, including short-term memory loss, mental abnormalities, hyponatremia and seizures characterized by faciobrachial dystonic seizures and who was diagnosed with anti-LGI1 encephalitis. At the same time, he was diagnosed with essential thrombocythemia. A significant improvement was obtained by treatment with corticosteroid, immunoglobulin, mycophenolate mofetil, and hydroxyurea. Autoimmune diseases are associated with a significantly increased risk of developing myeloproliferative neoplasms, which may explain the coexistence of anti-LGI1 encephalitis and essential thrombocythema in this patient; however, but more cases and studies are needed to determine whether there is any correlation between these conditions.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Correspondence to Dr. Lifeng Liu, hima2002@163.com
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.2963-19